Côd QR

Comparing immunotherapy re-challenge plus chemoradiotherapy versus chemoradiotherapy alone in metastatic esophageal squamous cell carcinoma after first-line immunotherapy failure

Abstract Background Immunotherapy (IO) re-challenge for cancer patients has sparked widespread discussion and attention in recent years. The optimal second-line treatment strategies for patients with metastatic esophageal squamous cell carcinoma (ESCC) after first-line IO failure remains to be furth...

Disgrifiad llawn

Wedi'i Gadw mewn:
Prif Awduron: Jian Song, Jie Shu, Wensi Zhao
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer 2026-05-01
Cyfres:Discover Oncology
Pynciau:
Esophageal squamous cell carcinoma
Immunotherapy
Re-challenge
Chemoradiotherapy
Second-line therapy
Mynediad Ar-lein:https://doi.org/10.1007/s12672-026-05149-z
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg